Model
Edge
Albireo Pharma, Inc.
0001322505
Filing type
8-K
Filing date
Mar 1, 2023
Updated
Mar 2, 2023 ยท 9:27 AM
Copy reference
Filing
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
Exhibits
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2